Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc.verified

ATRA

Price:

$0.61

Market Cap:

$73.45M

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of...[Read more]

Industry

Biotechnology

IPO Date

2014-10-16

Stock Exchange

NASDAQ

Ticker

ATRA

The Current Ratio as of May 2024 (TTM) for Atara Biotherapeutics, Inc. (ATRA) is 0.59

According to Atara Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.59. This represents a change of -53.96% compared to the average of 1.28 of the last 4 quarters.

Atara Biotherapeutics, Inc. (ATRA) Historical Current Ratio (quarterly & annually)

How has ATRA Current Ratio performed in the past?

The mean historical Current Ratio of Atara Biotherapeutics, Inc. over the last ten years is 13.54. The current 0.59 Current Ratio has changed 335.07% with respect to the historical average. Over the past ten years (40 quarters), ATRA's Current Ratio was at its highest in in the September 2015 quarter at 52.75. The Current Ratio was at its lowest in in the March 2024 quarter at 0.59.

Quarterly (TTM)
Annual

Average

13.54

Median

6.87

Minimum

0.72

Maximum

38.92

Atara Biotherapeutics, Inc. (ATRA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Atara Biotherapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 29.11%

Maximum Annual Current Ratio = 38.92

Minimum Annual Increase = -80.84%

Minimum Annual Current Ratio = 0.72

Quarterly (TTM)
Annual
YearCurrent RatioChange
20230.72-80.84%
20223.742.84%
20213.64-42.40%
20206.31-15.04%
20197.43-7.61%
20188.0429.11%
20176.23-76.87%
201626.93-19.45%
201533.43-14.11%
201438.9214.50%

Atara Biotherapeutics, Inc. (ATRA) Average Current Ratio

How has ATRA Current Ratio performed in the past?

The current Current Ratio of Atara Biotherapeutics, Inc. (ATRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.70

5-year avg

4.37

10-year avg

13.54

Atara Biotherapeutics, Inc. (ATRA) Current Ratio vs. Peers

How is ATRA’s Current Ratio compared to its peers?

Atara Biotherapeutics, Inc.’s Current Ratio is less than Fate Therapeutics, Inc. (8.69), less than Sana Biotechnology, Inc. (6.07), less than Caribou Biosciences, Inc. (10.49), less than Arcus Biosciences, Inc. (5.22), less than Heron Therapeutics, Inc. (2.47), less than Allogene Therapeutics, Inc. (12.80), less than BioXcel Therapeutics, Inc. (2.57), less than Karyopharm Therapeutics Inc. (3.04), less than X4 Pharmaceuticals, Inc. (3.71), less than HOOKIPA Pharma Inc. (4.50), less than Mereo BioPharma Group plc (4.86), less than Galera Therapeutics, Inc. (7.54), less than Acumen Pharmaceuticals, Inc. (30.20), less than VectivBio Holding AG (9.14), less than Icosavax, Inc. (18.06), less than Apellis Pharmaceuticals, Inc. (3.77), less than iTeos Therapeutics, Inc. (13.51), less than TScan Therapeutics, Inc. (5.23),

Build a custom stock screener for Atara Biotherapeutics, Inc. (ATRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atara Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atara Biotherapeutics, Inc. (ATRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atara Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Atara Biotherapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Atara Biotherapeutics, Inc. (ATRA)?

What is the highest Current Ratio for Atara Biotherapeutics, Inc. (ATRA)?

What is the 3-year average Current Ratio for Atara Biotherapeutics, Inc. (ATRA)?

What is the 5-year average Current Ratio for Atara Biotherapeutics, Inc. (ATRA)?

How does the current Current Ratio for Atara Biotherapeutics, Inc. (ATRA) compare to its historical average?